多中心、随机 (1:1)、对照 2 期刺激 VG 清创术和全身抗生素疗程与标准护理 (SOC) 对比治疗与 IV 期压疮相关的骨髓炎。 (BLADE OPU2)
The purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage IV pressure ulcers.
研究概览
详细说明
The trial is an open-label, multi-center, randomized (1:1), controlled phase 2 trial in patients diagnosed with stage IV pressure ulcers.
研究类型
注册 (估计的)
阶段
- 阶段2
扩展访问
联系人和位置
学习联系方式
- 姓名:Keira Watts, Clinical Research Director
- 电话号码:+44 (0) 1782 338 580
- 邮箱:clinicaltrials@biocomposites.com
研究联系人备份
- 姓名:Daniel Roberts
- 邮箱:droberts@mcra.com
学习地点
-
-
Arizona
-
Phoenix、Arizona、美国、85032
- 招聘中
- Advanced Foot Care, LLC
-
首席研究员:
- Jaminelli Banks, DPM
-
接触:
- Rajashekhar Ittedi
- 电话号码:(480) 863-6044
- 邮箱:rajaittedi123@gmail.com)
-
接触:
- Krishna Sai Penumarthi
- 电话号码:(480) 863-6044
- 邮箱:kspenumarthi@axentrabio.com
-
-
Illinois
-
Chicago、Illinois、美国、60611
- 招聘中
- Northwestern University Feinberg School of Medicine
-
首席研究员:
- Robert Galiano, MD
-
接触:
- Brigid Coles
- 电话号码:312-503-3209
- 邮箱:brigid.coles@nm.org
-
接触:
- Tarifa Adam
- 电话号码:312-503-3209
- 邮箱:tarifa.adam@nm.org
-
-
Michigan
-
Detroit、Michigan、美国、48202
- 招聘中
- Henry Ford Hospital
-
首席研究员:
- Aamir Siddiqui, MD
-
接触:
- Sarah Meehan
- 邮箱:smeehan1@hfhs.org
-
接触:
- Dan Molitor
- 邮箱:dmolito2@hfhs.org
-
-
Mississippi
-
Jackson、Mississippi、美国、39216
- 招聘中
- University of Mississippi Medical Center
-
接触:
- Venkata Seerapu
- 邮箱:vseerapu@umc.edu
-
接触:
- Laxmi Dhungel
- 邮箱:idhungel@umc.edu
-
首席研究员:
- Ian Hoppe, MD
-
-
Missouri
-
Columbia、Missouri、美国、65201
- 招聘中
- Missouri Orthopaedic Institute
-
首席研究员:
- Brett Crist, MD
-
接触:
- Andrew Monhollen
- 邮箱:am5hf@health.missouri.edu
-
接触:
- Vicki Jones
- 邮箱:jonesvicki@health.missouri.edu
-
-
Nebraska
-
Omaha、Nebraska、美国、68198
- 招聘中
- University of Nebraska Medical Center
-
接触:
- Katie Ostlund
- 邮箱:katie.ostlund@unmc.edu
-
接触:
- Gabriel Gauthier
- 邮箱:gabriel.gauthier@unmc.edu
-
首席研究员:
- James Willcockson, MD
-
-
New Jersey
-
Newark、New Jersey、美国、07103
- 招聘中
- Rutgers New Jersey Medical School
-
接触:
- Mehreen Bhatti
- 邮箱:mb2276@njms.rutgers.edu
-
接触:
- Saharsh Patel
- 邮箱:ssp186@gsbs.rutgers.edu
-
首席研究员:
- Alex Wong, MD, FACS
-
-
New York
-
Mineola、New York、美国、11501
- 招聘中
- NYU Langone Hospital - Long Island Clinical Research Center
-
首席研究员:
- Scott Gorenstein, MD
-
接触:
- Monica Benitez
- 电话号码:516 663 9582
- 邮箱:monica.benitez@nyulangone.org
-
接触:
- Anita Farha
- 电话号码:516 663 9582
- 邮箱:anita.farhi@nyulangone.org
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、美国、15219
- 招聘中
- University of Pittsburgh, McGowan Institute for Regenerative Medicine
-
接触:
- Urmila Gnyawali
- 电话号码:412-624-5500
- 邮箱:usg2@pitt.edu
-
接触:
- Scot King
- 电话号码:412-624-5500
- 邮箱:scot.king@pitt.edu
-
首席研究员:
- Sashwati Roy, PhD, MS
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
In order to be eligible to participate in this study, subjects must meet all of the following criteria:
- Presenting with a Stage IV pressure ulcer requiring treatment of excision, bony debridement and flap coverage/primary closure.
- Operative candidate for flap surgery or primary closure.
- Presence of focal osteomyelitis as suggested by imaging to show extent of infection. Acceptable imaging techniques are Magnetic Resonance Imaging or CT scan.
- Adults ≥ 18 years in age at the time of treatment.
- Psychosocially, mentally, and physically able to fully comply with this protocol, including adhering to scheduled visits, treatment plan, completing forms, and other study procedures.
- Ability of the subject or legal authorized representative to provide voluntary, signed and dated informed consent prior to any study-related procedures.
Subjects who meet any of the following criteria will be excluded from participating in this study:
-
Reasons contributing to pressure ulcer cannot be addressed.
-
Severe immunological compromised patients as determined by the clinician.
-
Patients with diffuse or widespread pelvic osteomyelitis that is not amenable to adequate margins for debridement.
-
Patients presenting with head pressure ulcers.
-
Current or recent history (within last 2 years) of active substance abuse (e.g., recreational drugs, narcotics, or alcohol) that in the judgement of the investigator, may compromise the participant's safety/recovery or ability to follow the trial procedures.
-
Current smoker.
-
Diabetic patient with Hba1C level above 9.
-
Allergy to any component of the investigational product, such as calcium sulfate, glycopeptide antibiotics (Vancomycin), or aminoglycoside antibiotics (Gentamicin).
-
Concurrent involvement in a study of another investigational product.
-
Pregnant or planning to become pregnant during study period.
-
Flexion contractures where patient cannot passively get full extension.
-
Uncontrolled muscle spasms.
-
Unable to comply with bedrest restriction or offloading requirements
-
Unable to provide consent.
-
Fecal or urinary incontinence with contamination of the wound.
-
Lower extremity pressure ulcer location that is vascularly compromised as defined by an Ankle Brachial Index ≤ 0.7 mm Hg OR toe brachial index ≤ 0.6 mm OR toe pressure ≤ 40 mm Hg OR transcutaneous oximetry ≤ 40 mm Hg *
-
Investigator considers the participant to be clinically malnourished.
-
Any conditions with known hypercalcemia (> 10.3 mg/dl) or posing a significant risk for developing hypercalcemia (i.e., Hyperparathyroidism).
-
Investigator believes trial participation may compromise safety of the participant or trial results.
- Patients presenting with lower extremity pressure ulcers that are vascularly compromised can be rescreened followed successful revascularization
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Interventional STIMULAN VG
Ulcer bursectomy and debridement and STIMULAN VG insertion into the ulcer cavity. Flap/primary closure. Peri-operative antibiotics. |
Insertion of STIMULAN VG into the ulcer cavity prior to flap/primary closure. Standard of Care. Ulcer bursectomy, debridement and flap/primary closure. Peri-operative antibiotics. |
|
有源比较器:Standard of Care (SoC)
Ulcer bursectomy, debridement and flap/primary closure. Peri-operative antibiotics. |
Standard of Care. Ulcer bursectomy, debridement and flap/primary closure. Peri-operative antibiotics. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Individual patient success and findings at the 8 week follow-up visit
大体时间:8 week
|
An individual patient treatment will be considered a success if there is complete wound closure and healing at the surgical site at two consecutive visits 2 weeks apart. |
8 week
|
合作者和调查者
合作者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.